Lipoprotein(a) Reduction in Persons with Cardiovascular Disease | Zendy

Sotirios Tsimikas | Zendy; Ewa KarwatowskaProkopczuk | Zendy; Ioanna GouniBerthold | Zendy; JeanClaude Tardif | Zendy; Seth J. Baum | Zendy; Elizabeth Steinhagen-Thiessen | Zendy; Michael D. Shapiro | Zendy; Erik S.G. Stroes | Zendy; Patrick M. Moriarty | Zendy; Børge G. Nordestgaard | Zendy; Shuting Xia | Zendy; Jonathan Guerriero | Zendy; Nicholas J. Viney | Zendy; Louis O’Dea | Zendy; Joseph L. Witztum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

Author(s) -

Sotirios Tsimikas,

Ewa KarwatowskaProkopczuk,

Ioanna GouniBerthold,

JeanClaude Tardif,

Seth J. Baum,

Elizabeth Steinhagen-Thiessen,

Michael D. Shapiro,

Erik S.G. Stroes,

Patrick M. Moriarty,

Børge G. Nordestgaard,

Shuting Xia,

Jonathan Guerriero,

Nicholas J. Viney,

Louis O’Dea,

Joseph L. Witztum

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1905239

Subject(s) - medicine , lipoprotein(a) , reduction (mathematics) , disease , ldl cholesterol , atherosclerotic cardiovascular disease , lipoprotein , cholesterol , cardiology , geometry , mathematics

Lipoprotein(a) levels are genetically determined and, when elevated, are a risk factor for cardiovascular disease and aortic stenosis. There are no approved pharmacologic therapies to lower lipoprotein(a) levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research